Drug intelligence / Profile preview

donepezil + yokukansankachimpihange

Development stage
Preclinical
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Oral
01

Overview

Donepezil + yokukansankachimpihange is a combination therapy consisting of donepezil, a reversible acetylcholinesterase inhibitor, and yokukansankachimpihange (YKSCH), a traditional Japanese Kampo herbal medicine. Donepezil increases acetylcholine levels in the brain by inhibiting its breakdown, thereby improving cognitive function in Alzheimer's disease. Yokukansankachimpihange is composed of the herbal formula yokukansan with added Citrus unshiu peel and Pinellia tuber; it is used to treat behavioral and psychological symptoms of dementia (BPSD) such as agitation, hallucinations, and irritability. YKSCH acts through modulation of serotonergic (notably 5-HT1A receptor partial agonism) and glutamatergic neurotransmission, as well as possible dopaminergic effects. The combination aims to address both cognitive decline (via donepezil) and neuropsychiatric symptoms (via YKSCH), with studies suggesting reduced need for antipsychotics when both are used together[1][3][6][7].

02

Targets

AcetylcholinesteraseEAAT3 (Excitatory amino acid transporter 3)SIGMAR1 (Sigma non-opioid intracellular receptor 1)

Beyond the preview

Go deeper on donepezil + yokukansankachimpihange.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on donepezil + yokukansankachimpihange.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call